Overview

This is an Open-Label Study to Assess the Safety and Efficacy of GC012F in Patients With Multiple Sclerosis

Status:
NOT_YET_RECRUITING
Trial end date:
2029-12-10
Target enrollment:
Participant gender:
Summary
This is an open-label,early-stage exploratory clinical study to evaluate the safety and preliminary efficacy of GC012F CAR T cell injection in Multiple Sclerosis subjects.
Phase:
EARLY_PHASE1
Details
Lead Sponsor:
Huashan Hospital